156 related articles for article (PubMed ID: 23533617)
1. Dual role of G-runs and hnRNP F in the regulation of a mutation-activated pseudoexon in the fibrinogen gamma-chain transcript.
Rimoldi V; Soldà G; Asselta R; Spena S; Stuani C; Buratti E; Duga S
PLoS One; 2013; 8(3):e59333. PubMed ID: 23533617
[TBL] [Abstract][Full Text] [Related]
2. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
[TBL] [Abstract][Full Text] [Related]
3. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
4. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene.
Chen CD; Kobayashi R; Helfman DM
Genes Dev; 1999 Mar; 13(5):593-606. PubMed ID: 10072387
[TBL] [Abstract][Full Text] [Related]
5. hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc.
Mauger DM; Lin C; Garcia-Blanco MA
Mol Cell Biol; 2008 Sep; 28(17):5403-19. PubMed ID: 18573884
[TBL] [Abstract][Full Text] [Related]
6. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H'/F/2H9 family.
Caputi M; Zahler AM
J Biol Chem; 2001 Nov; 276(47):43850-9. PubMed ID: 11571276
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.
Chen X; Yang HT; Zhang B; Phillips JW; Cheng D; Rigo F; Witte ON; Xing Y; Black DL
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2220190120. PubMed ID: 37399401
[TBL] [Abstract][Full Text] [Related]
8. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.
Masuda A; Shen XM; Ito M; Matsuura T; Engel AG; Ohno K
Hum Mol Genet; 2008 Dec; 17(24):4022-35. PubMed ID: 18806275
[TBL] [Abstract][Full Text] [Related]
9. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
[TBL] [Abstract][Full Text] [Related]
10. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
11. hnRNP H1 and intronic G runs in the splicing control of the human rpL3 gene.
Russo A; Siciliano G; Catillo M; Giangrande C; Amoresano A; Pucci P; Pietropaolo C; Russo G
Biochim Biophys Acta; 2010; 1799(5-6):419-28. PubMed ID: 20100605
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous nuclear ribonucleoprotein H is required for optimal U11 small nuclear ribonucleoprotein binding to a retroviral RNA-processing control element: implications for U12-dependent RNA splicing.
McNally LM; Yee L; McNally MT
J Biol Chem; 2006 Feb; 281(5):2478-88. PubMed ID: 16308319
[TBL] [Abstract][Full Text] [Related]
13. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
Zhu J; Mayeda A; Krainer AR
Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
[TBL] [Abstract][Full Text] [Related]
14. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells.
Chou MY; Rooke N; Turck CW; Black DL
Mol Cell Biol; 1999 Jan; 19(1):69-77. PubMed ID: 9858532
[TBL] [Abstract][Full Text] [Related]
15. hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2).
Tang X; Kane VD; Morré DM; Morré DJ
Mol Cell Biochem; 2011 Nov; 357(1-2):55-63. PubMed ID: 21625959
[TBL] [Abstract][Full Text] [Related]
16. Encoded Conformational Dynamics of the HIV Splice Site A3 Regulatory Locus: Implications for Differential Binding of hnRNP Splicing Auxiliary Factors.
Chiu LY; Emery A; Jain N; Sugarman A; Kendrick N; Luo L; Ford W; Swanstrom R; Tolbert BS
J Mol Biol; 2022 Sep; 434(18):167728. PubMed ID: 35870649
[TBL] [Abstract][Full Text] [Related]
17. SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome.
Rahman MA; Azuma Y; Nasrin F; Takeda J; Nazim M; Bin Ahsan K; Masuda A; Engel AG; Ohno K
Sci Rep; 2015 Aug; 5():13208. PubMed ID: 26282582
[TBL] [Abstract][Full Text] [Related]
18. Binding of hnRNP H and U2AF65 to respective G-codes and a poly-uridine tract collaborate in the N50-5'ss selection of the REST N exon in H69 cells.
Ortuño-Pineda C; Galindo-Rosales JM; Calderón-Salinas JV; Villegas-Sepúlveda N; Saucedo-Cárdenas O; De Nova-Ocampo M; Valdés J
PLoS One; 2012; 7(7):e40315. PubMed ID: 22792276
[TBL] [Abstract][Full Text] [Related]
19. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.
Caputi M; Zahler AM
EMBO J; 2002 Feb; 21(4):845-55. PubMed ID: 11847131
[TBL] [Abstract][Full Text] [Related]
20. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
Damgaard CK; Tange TO; Kjems J
RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]